Given that enhancing Ctsd activity could potentially reduce Aβ42 levels 21, we investigated whether demethylation of Ctsd via dCas9-Tet1 in the mouse brain could decrease Aβ42 levels and alleviate cognitive and memory impairments in the 5xFAD mouse model. Here, TET1 is linked to memory impairment.